On ECHEMI
Home > Drugs > Zhejiang Xianju Pharmaceutical Co., Ltd.
Zhejiang Xianju Pharmaceutical Co., Ltd.
  • Founded in:

    2000-06-26
  • Country:

    China China
  • Address:

    No. 1, Xianyao Road, Xianju County, Taizhou City, Zhejiang Province
  • Tax NO.:

    913300007047892221
  • Registered Funds:

    989.204866 million yuan
  • Website:

  • Email:

Related Drugs
Finasteride Tablets
The main ingredient of this product is finasteride.
Name Description Content CAS NO. Registered Holders
Finasteride

Finasteride is a synthetic steroid compound that is a specific inhibitor of the intracellular enzyme type II 5α-reductase in the process of metabolizing the androgen testosterone into dihydrotestosterone. Finasteride has no affinity for androgen receptors and has no androgenic, anti-androgenic, estrogen-like, anti-estrogen-like or progestational effects. Inhibition of this enzyme can hinder the conversion of testosterone to the androgen dihydrotestosterone in peripheral tissues, significantly reducing the concentration of dihydrotestosterone in serum and tissues. Compared with placebo, it can increase the level of testosterone in the blood circulation by about 10-15%, but it is still within the physiological range. Finasteride can rapidly reduce the concentration of dihydrotestosterone in serum and significantly reduce it within 24 hours after administration. Administration of finasteride can reduce the concentration of dihydrotestosterone in the scalp and serum of these patients. Men who are congenitally deficient in type II 5α-reductase will not suffer from male baldness. These data and the results of clinical studies confirm that finasteride can inhibit the shrinkage of scalp hair follicles and reverse the process of hair loss.

More

Finasteride is a synthetic steroid compound that is a specific inhibitor of the intracellular enzyme type II 5α-reductase in the process of metabolizing the androgen testosterone into dihydrotestosterone. Finasteride has no affinity for androgen receptors and has no androgenic, anti-androgenic, estrogen-like, anti-estrogen-like or progestational effects. Inhibition of this enzyme can hinder the conversion of testosterone to the androgen dihydrotestosterone in peripheral tissues, significantly reducing the concentration of dihydrotestosterone in serum and tissues. Compared with placebo, it can increase the level of testosterone in the blood circulation by about 10-15%, but it is still within the physiological range. Finasteride can rapidly reduce the concentration of dihydrotestosterone in serum and significantly reduce it within 24 hours after administration. Administration of finasteride can reduce the concentration of dihydrotestosterone in the scalp and serum of these patients. Men who are congenitally deficient in type II 5α-reductase will not suffer from male baldness. These data and the results of clinical studies confirm that finasteride can inhibit the shrinkage of scalp hair follicles and reverse the process of hair loss.

98319-26-7 50
Estradiol Benzoate
Name Description Content CAS NO. Registered Holders
Estradiol benzoate

Unspecified

More

Unspecified

50-50-0 9
Estradiol
Name Description Content CAS NO. Registered Holders
β-Estradiol

Extract from the above information

More

Extract from the above information

50-28-2 12
Medroxyprogesterone acetate
Name Description Content CAS NO. Registered Holders
Medroxyprogesterone Acetate

Unspecified

More

Unspecified

71-58-9 22
Ethinyl estradiol
Name Description Content CAS NO. Registered Holders
Ethinyl Estradiol

Unspecified

More

Unspecified

57-63-6 21
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.